AI takes aim at lung cancer: smarter radiation doses could reduce recurrence

This study is testing whether artificial intelligence (AI) can help doctors choose the right radiation dose for people with lung cancer or tumors that have spread to the lung. The treatment uses a precise type of radiation called SBRT, and the AI aims to personalize the dose to each patient's tumor to lower the chance of the cancer coming back. The study will enroll about 70 participants and follow them for up to 5 years to see how well the AI-guided approach works.